PRICE T ROWE ASSOCIATES INC /MD/ - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$791
-47.5%
331,861
+5.5%
0.00%
Q2 2023$1,507
-54.5%
314,427
-46.2%
0.00%
Q1 2023$3,313
+1.5%
584,072
+0.3%
0.00%
-100.0%
Q4 2022$3,263
-99.9%
582,544
+1.7%
0.00%0.0%
Q3 2022$3,680,000
+88.6%
572,991
+0.8%
0.00%
Q2 2022$1,951,000
-51.8%
568,709
+0.1%
0.00%
Q1 2022$4,046,000
-13.3%
568,209
+1.4%
0.00%
Q4 2021$4,669,000
-50.7%
560,564
-58.8%
0.00%
-100.0%
Q3 2021$9,469,000
-71.4%
1,360,523
-2.0%
0.00%
-66.7%
Q2 2021$33,100,000
+13.4%
1,387,839
-2.1%
0.00%0.0%
Q1 2021$29,183,000
-36.8%
1,417,342
-24.7%
0.00%
-40.0%
Q4 2020$46,140,000
+180.0%
1,883,260
+223.5%
0.01%
+150.0%
Q3 2020$16,481,000
+13084.8%
582,151
+2123.6%
0.00%
Q2 2020$125,000
-35.6%
26,180
-51.7%
0.00%
Q1 2020$194,000
+4.3%
54,234
+0.6%
0.00%
Q4 2019$186,000
-11.4%
53,934
+2.9%
0.00%
Q3 2019$210,000
+25.7%
52,433
+0.8%
0.00%
Q2 2019$167,000
-73.1%
52,008
-42.5%
0.00%
Q1 2019$621,000
+33.0%
90,377
-12.5%
0.00%
Q4 2018$467,000
-40.4%
103,287
+0.0%
0.00%
Q3 2018$784,000
-11.6%
103,247
+0.1%
0.00%
Q2 2018$887,000
+17.2%
103,1010.0%0.00%
Q1 2018$757,000
-27.6%
103,101
+0.0%
0.00%
Q4 2017$1,045,000
-84.8%
103,061
-75.9%
0.00%
-100.0%
Q3 2017$6,861,000
+30.7%
427,723
-7.9%
0.00%0.0%
Q2 2017$5,248,000
-35.0%
464,423
-35.2%
0.00%
-50.0%
Q1 2017$8,078,000
+8.5%
716,795
-4.6%
0.00%
+100.0%
Q4 2016$7,442,000
-19.6%
751,680
-0.2%
0.00%
-50.0%
Q3 2016$9,260,000
-72.2%
753,480
-34.3%
0.00%
-71.4%
Q2 2016$33,337,000
+32.0%
1,147,577
+20.7%
0.01%
+40.0%
Q1 2016$25,254,000
-25.2%
950,830
-1.1%
0.01%
-28.6%
Q4 2015$33,744,000
+21.3%
961,650
+0.3%
0.01%
+16.7%
Q3 2015$27,816,000
-28.7%
959,010
-0.2%
0.01%
-25.0%
Q2 2015$39,032,000961,0760.01%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders